Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium haematin detoxification system is a vital metabolic pathway employed by Plasmodium species to neutralize the toxic byproducts of hemoglobin digestion (Sullivan, 2002, PMID: 12456505). During the parasite's intraerythrocytic stage, it consumes host hemoglobin, releasing free heme (ferriprotoporphyrin IX), which is highly toxic due to its ability to generate reactive oxygen species and disrupt lipid membranes (Egan, 2008, DOI: 10.1016/j.drudis.2008.01.004). To survive, the parasite converts this free heme into an insoluble, non-toxic crystalline polymer called hemozoin within its acidic food vacuole (Hempelmann, 2007, PMID: 17368387). This process is often facilitated by the Heme Detoxification Protein (HDP) and specific lipid environments (Jani et al., 2008, PMID: 18451171). This system serves as the pharmacological target for quinoline-based antimalarials, such as chloroquine and quinine, which bind to heme or the growing crystal face to inhibit further detoxification (Coronado et al., 2014, PMID: 24954177). The resulting accumulation of free heme leads to parasite death, making this system one of the most successful targets in antimalarial chemotherapy.
Inhibition of heme biocrystallization into hemozoin, leading to the accumulation of toxic free ferriprotoporphyrin IX (Sullivan, 2002, PMID: 12456505).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium haematin detoxification system (HDS).